Glyprovac

Developer of glycoprotein-based vaccine against bacterial infections

placeOdense, Region Of Southern Denmark, Denmark calendar_todayFounded 2015 groups3 employees language glyprovac.com

Registered entities

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 91 times.

YearFilings
20241
20252

Social engagement

Social engagement: 1.2K social following, 2 posts in the last 12 months — top 10% of its industry.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

5 Nov 2025
Event
BactiVac annual meeting
Coming soon